$NAUT 4 SEC Filings

Filed On	Filing
22 Jun 2026	Form 4: Posard Matthew L., Director Granted 45,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Nazem Farzad, Director Granted 45,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Akinsanya Karen, Director Granted 45,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: McIlwain Matthew S, Director Granted 45,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Epperly Melissa B,, Director Granted 45,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Ah Equity Partners Bio II, L.l.c., 10% owner and 5 others Sold 5,000,000 shares ($11.8M)
04 Mar 2026	Form 4: Patel Sujal M, Director Bought 25,000 shares ($65.2K)
04 Mar 2026	Form 4: Mowry Anna, CFO and Treasurer Granted 160,000 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Mallick Parag, Director Granted 280,000 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Patel Sujal M, Director Granted 650,000 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Sankar Subramanian, Senior VP, Product Development Granted 160,000 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Weld Gwen E, Chief People Officer Granted 160,000 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Murphy Matthew B., General Counsel Granted 160,000 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Suzuki Kentaro, Chief Marketing Officer Granted 160,000 Stock Option (Right to Buy)
10 Nov 2025	Form 4: Suzuki Kentaro, Chief Marketing Officer Bought 4,000 shares ($5.96K)
09 Sep 2025	Form 4: Patel Sujal M, Director Bought 116,500 shares ($78.5K) · Bought 83,500 shares ($57K)
05 Sep 2025	Form 4: Murphy Matthew B., General Counsel Bought 20,000 shares ($12.9K)
25 Jun 2025	Form 4: Epperly Melissa B,, Director Granted 45,000 Stock Option (Right to Buy)
25 Jun 2025	Form 4: Posard Matthew L., Director Granted 45,000 Stock Option (Right to Buy)
25 Jun 2025	Form 4: McIlwain Matthew S, Director Granted 45,000 Stock Option (Right to Buy)

Comments